Camden National Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $336K | Buy |
11,965
+123
| +1% | +$3.27K | 0.05% | 121 |
|
|
2025
Q4 | $295K | Buy |
11,842
+501
| +4% | +$12.6K | 0.04% | 133 |
|
|
2025
Q3 | $289K | Buy |
11,341
+100
| +0.9% | +$2.47K | 0.04% | 131 |
|
|
2025
Q2 | $272K | Sell |
11,241
-614
| -5% | -$14.3K | 0.04% | 133 |
|
|
2025
Q1 | $300K | Hold |
11,855
| – | – | 0.04% | 124 |
|
|
2024
Q4 | $315K | Sell |
11,855
-152
| -1% | -$4.12K | 0.05% | 121 |
|
|
2024
Q3 | $347K | Hold |
12,007
| – | – | 0.05% | 114 |
|
|
2024
Q2 | $336K | Sell |
12,007
-18
| -0.1% | -$496 | 0.05% | 107 |
|
|
2024
Q1 | $334K | Sell |
12,025
-275
| -2% | -$7.63K | 0.06% | 104 |
|
|
2023
Q4 | $354K | Sell |
12,300
-3,846
| -24% | -$116K | 0.07% | 97 |
|
|
2023
Q3 | $536K | Sell |
16,146
-1,660
| -9% | -$58.7K | 0.11% | 81 |
|
|
2023
Q2 | $653K | Sell |
17,806
-2,097
| -11% | -$81.6K | 0.13% | 78 |
|
|
2023
Q1 | $812K | Buy |
19,903
+10,006
| +101% | +$432K | 0.16% | 73 |
|
|
2022
Q4 | $507K | Sell |
9,897
-4,084
| -29% | -$196K | 0.11% | 84 |
|
|
2022
Q3 | $612K | Sell |
13,981
-127
| -0.9% | -$6.17K | 0.14% | 80 |
|
|
2022
Q2 | $740K | Sell |
14,108
-80
| -0.6% | -$4.08K | 0.15% | 77 |
|
|
2022
Q1 | $735K | Sell |
14,188
-554
| -4% | -$28.7K | 0.13% | 81 |
|
|
2021
Q4 | $871K | Buy |
14,742
+252
| +2% | +$12.5K | 0.15% | 79 |
|
|
2021
Q3 | $623K | Sell |
14,490
-91
| -0.6% | -$4.03K | 0.12% | 84 |
|
|
2021
Q2 | $571K | Sell |
14,581
-993
| -6% | -$38.6K | 0.11% | 90 |
|
|
2021
Q1 | $565K | Buy |
15,574
+1,647
| +12% | +$58.5K | 0.11% | 86 |
|
|
2020
Q4 | $512K | Sell |
13,927
-2,687
| -16% | -$98.6K | 0.11% | 88 |
|
|
2020
Q3 | $578K | Sell |
16,614
-1,804
| -10% | -$63.2K | 0.13% | 81 |
|
|
2020
Q2 | $571K | Sell |
18,418
-959
| -5% | -$32.6K | 0.14% | 77 |
|
|
2020
Q1 | $600K | Sell |
19,377
-4,642
| -19% | -$158K | 0.16% | 70 |
|
|
2019
Q4 | $893K | Buy |
24,019
+172
| +0.7% | +$6.13K | 0.18% | 65 |
|
|
2019
Q3 | $813K | Buy |
23,847
+3,767
| +19% | +$137K | 0.18% | 63 |
|
|
2019
Q2 | $825K | Buy |
20,080
+7,975
| +66% | +$317K | 0.19% | 63 |
|
|
2019
Q1 | $488K | Buy |
12,105
+9
| +0.1% | +$360 | 0.12% | 72 |
|
|
2018
Q4 | $500K | Buy |
12,096
+2,508
| +26% | +$104K | 0.14% | 62 |
|
|
2018
Q3 | $401K | Buy |
9,588
+55
| +0.6% | +$2.12K | 0.1% | 76 |
|
|
2018
Q2 | $328K | Buy |
9,533
+985
| +12% | +$33.7K | 0.09% | 81 |
|
|
2018
Q1 | $288K | Hold |
8,548
| – | – | 0.08% | 76 |
|
|
2017
Q4 | $294K | Buy |
8,548
+1,038
| +14% | +$35.4K | 0.09% | 68 |
|
|
2017
Q3 | $255K | Buy |
7,510
+160
| +2% | +$5.14K | 0.08% | 68 |
|
|
2017
Q2 | $234K | Buy |
+7,350
| New | +$232K | 0.07% | 68 |
|
|
2017
Q1 | – | Sell |
-14,632
| Closed | -$451K | – | 76 |
|
|
2016
Q4 | $451K | Buy |
+14,632
| New | +$447K | 0.14% | 58 |
|
Other funds holding PFE
VCM
VPM
Camden National Bank's PFE Position: Q1 2026 in Review
Camden National Bank increased its Pfizer (PFE) stake by 1% in Q1 2026, buying an estimated $3.27K and bringing the position to 11,965 shares worth $336K. The position accounts for 0.05% of the portfolio, ranked #121.
Camden National Bank first reported a position in PFE in Q4 2016 and has held it in 37 quarters since. The position peaked at $893K in Q4 2019. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Camden National Bank held 11,965 shares of Pfizer worth $336K as of Q1 2026.
- Camden National Bank bought 123 Pfizer shares in Q1 2026, an estimated $3.27K.
- Pfizer made up 0.05% of Camden National Bank's portfolio in Q1 2026, its #121 holding.
- Camden National Bank first reported a position in Pfizer in Q4 2016 and has held it in 37 quarters since.
- Camden National Bank's Pfizer position peaked at $893K in Q4 2019.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Camden National Bank's 13F filing for Q1 2026, filed 4 May 2026.